FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Astrid van der Veldt

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Idris Bahce; Daniëlle A M Heideman; Adriaan A Lammertsma; Mark Lubberink; Pieter E Postmus; Robert Schuit; Egbert F Smit; Erik Thunnissen; Astrid A M van der Veldt; Albert D Windhorst; Maqsood Yaqub; N Harry Hendrikse
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status.
Astrid A M van der Veldt; Adriaan A Lammertsma; Egbert F Smit
Scheduling of anticancer drugs: timing may be everything.
Astrid A M van der Veldt; Victor W M van Hinsbergh; Laura Vroling; Henk J Broxterman; Richard R de Haas; John B A G Haanen; PIETER KOOLWIJK; Alfons J M van den Eertwegh; Epie Boven
Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Astrid van der Veldt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Idris Bahce; Daniëlle A M Heideman; Adriaan A Lammertsma; Mark Lubberink; Pieter E Postmus; Robert Schuit; Egbert F Smit; Erik Thunnissen; Astrid A M van der Veldt; Albert D Windhorst; Maqsood Yaqub; N Harry Hendrikse
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(1):183-93.
2012: Astrid A M van der Veldt; Adriaan A Lammertsma; Egbert F Smit
Scheduling of anticancer drugs: timing may be everything.
Cell cycle (Georgetown, Tex.) 2012;11(23):4339-43.
2012: Astrid A M van der Veldt; Victor W M van Hinsbergh; Laura Vroling; Henk J Broxterman; Richard R de Haas; John B A G Haanen; PIETER KOOLWIJK; Alfons J M van den Eertwegh; Epie Boven
Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer.
International journal of cancer. Journal international du cancer 2012;131(4):E484-93.
2012: Astrid A M van der Veldt; Egbert F Smit
Bevacizumab in neoadjuvant treatment for breast cancer.
The New England journal of medicine 2012;366(17):1637; author reply 1638-40.
2012: Astrid A M van der Veldt; Hendrik Verheul; Maudy Walraven; Albert D Windhorst; Idris Bahce; Michiel P de Boer; Jonas Eriksson; Henri N J M Greuter; N Harry Hendrikse; Adriaan A Lammertsma; Mark Lubberink; Pieter E Postmus; Erik H Serné; Egbert F Smit
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs.
Cancer cell 2012;21(1):82-91.
2011: Astrid A M van der Veldt; Adriaan A Lammertsma; Mark Lubberink; Egbert F Smit
Comment on Cho et al.: Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.
European radiology 2011;21(10):2148-9; author reply 2150.
2011: Astrid A M van der Veldt; Arthur van Lingen; Albert D Windhorst; Maqsood Yaqub; Emile F I Comans; Henri N Greuter; N Harry Hendrikse; Gerarda J Herder; Mark Lubberink; Martien P J Mooijer; Anneloes Y Rijnders; S Nafees Rizvi; Robert C Schuit; Egbert F Smit; Adriaan A Lammertsma
Absolute quantification of [(11)C]docetaxel kinetics in lung cancer patients using positron emission tomography.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(14):4814-24.
2011: Astrid A M van der Veldt; Sebastiaan A Kleijn
Advances in pancreatic neuroendocrine tumor treatment.
The New England journal of medicine 2011;364(19):1873; author reply 1873-5.
2011: Astrid A M van der Veldt; Karel Eechoute; Hans Gelderblom; Jourik Gietema; Henk-Jan Guchelaar; Nielka P H van Erp; Alfons J M van den Eertwegh; John B A G Haanen; Ron H J Mathijssen; Judith A M Wessels
Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(3):620-9.
2010: Astrid A M van der Veldt; John B A G Haanen; Alfons J M van den Eertwegh; Epie Boven
Targeted therapy for renal cell cancer: current perspectives.
Discovery medicine 2010;10(54):394-405.
2010: Astrid A M van der Veldt; N Harry Hendrikse; Hendrik J Harms; Emile F I Comans; Pieter E Postmus; Egbert F Smit; Adriaan A Lammertsma; Mark Lubberink
Quantitative parametric perfusion images using 15O-labeled water and a clinical PET/CT scanner: test-retest variability in lung cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(11):1684-90.
2010: Martijn R Meijerink; Jan-Hein T M van Waesberghe; Cors van Schaik; Epie Boven; Astrid A M van der Veldt; Petrousjka van den Tol; Sybren Meijer; Cornelis van Kuijk
Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities.
Ultrasound in medicine & biology 2010;36(10):1626-36.
2010: Astrid A M van der Veldt; N Harry Hendrikse; Egbert F Smit; Martien P J Mooijer; Anneloes Y Rijnders; Winald Gerritsen; Jacobus J M van Der Hoeven; Albert D Windhorst; Adriaan A Lammertsma; Mark Lubberink
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.
European journal of nuclear medicine and molecular imaging 2010;37(10):1950-8.
2010: Astrid A M van der Veldt; Martijn R Meijerink; Alfons J M van den Eertwegh; Epie Boven
Targeted therapies in renal cell cancer: recent developments in imaging.
Targeted oncology 2010;5(2):95-112.
2010: Axel Bex; Astrid A M van der Veldt; Christian Blank; Martijn R Meijerink; Epie Boven; John B A G Haanen
Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.
Acta oncologica (Stockholm, Sweden) 2010;49(4):520-3.
2010: Axel Bex; Astrid A M van der Veldt; Epie Boven; John B A G Haanen
Re: Surgical resection of renal cell carcinoma after targeted therapyA. A. Thomas, B. I. Rini, A. J. Stephenson, J. A. Garcia, A. Fergany, V. Krishnamurthi, A. C. Novick, I. S. Gill, E. A. Klein, M. Zhou and S. C. Campbell J Urol 2009; 182: 881-886.
The Journal of urology 2010;183(4):1646-7; author reply 1647.
2010: Astrid A M van der Veldt; Michiel P de Boer; Epie Boven; Etto C Eringa; Alfons J M van den Eertwegh; Victor W van Hinsbergh; Yvo M Smulders; Erik H Serné
Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib.
Anti-cancer drugs 2010;21(4):439-46.
2010: Astrid A M van der Veldt; M R Meijerink; Alfons J M van den Eertwegh; John B A G Haanen; Epie Boven
Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.
British journal of cancer 2010;102(5):803-9.
2009: Astrid A M van der Veldt; Epie Boven; Axel Bex
Re: Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. A. A. Thomas, B. I. Rini, B. R. Lane, J. Garcia, R. Dreicer, E. A. Klein, A. C. Novick And S. C. Campbell. J Urol 2009; 181: 518-523.
The Journal of urology 2009;182(2):797; author reply 797-8.
2009: Axel Bex; Astrid A M van der Veldt; Christian Blank; Alfons J M van den Eertwegh; Epie Boven; Simon Horenblas; John Haanen
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery.
World journal of urology 2009;27(4):533-9.
2009: Astrid A M van der Veldt; Sebastiaan A Kleijn; Prabath W Nanayakkara
Silicone breast implants and anaplastic large T-cell lymphoma.
JAMA : the journal of the American Medical Association 2009;301(12):1227; author reply 1227.
2009: Astrid A M van der Veldt; Epie Boven; Laura Vroling; Henk J Broxterman; Alfons J M van den Eertwegh; John G Haanen
Sunitinib-induced hemoglobin changes are related to the dosing schedule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(8):1339-40; author reply 1340-2.
2009: Laura Vroling; Astrid A M van der Veldt; Richard R de Haas; John B A G Haanen; Gerrit Jan Schuurhuis; Dirk J Kuik; Hester van Cruijsen; Hendrik Verheul; Alfons J M van den Eertwegh; Klaas Hoekman; Epie Boven; Victor W M van Hinsbergh; Henk J Broxterman
Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.
Angiogenesis 2009;12(1):69-79.
2008: Astrid A M van der Veldt; Marrije R Buist; Marchien W van Baal; Emile F I Comans; Otto S Hoekstra; Carla F M Molthoff
Clarifying the diagnosis of clinically suspected recurrence of cervical cancer: impact of 18F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(12):1936-43.
2008: Astrid A M van der Veldt; Merian van Wouwe; Alfons J M van den Eertwegh; R Jeroen A Van Moorselaar; Herman P van Geijn
Metastatic renal cell cancer in a 20-year-old pregnant woman.
Urology 2008;72(4):775; discussion 776-7.
2008: Hester van Cruijsen; Astrid A M van der Veldt; Laura Vroling; Dinja Oosterhoff; Henk J Broxterman; Rik J Scheper; Giuseppe Giaccone; John B A G Haanen; Alfons J M van den Eertwegh; Epie Boven; Klaas Hoekman; Tanja D de Gruijl
Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5884-92.
2008: Astrid A M van der Veldt; Epie Boven; H H Helgason; M van Wouwe; Johannes Berkhof; G de Gast; H Mallo; C N Tillier; Alfons J M van den Eertwegh; John B A G Haanen
Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.
British journal of cancer 2008;99(2):259-65.
2008: Astrid A M van der Veldt; Martijn R Meijerink; Alfons J M van den Eertwegh; Axel Bex; Gijsbert de Gast; John B A G Haanen; Epie Boven
Sunitinib for treatment of advanced renal cell cancer: primary tumor response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(8):2431-6.
2008: Lotty Hooft; Astrid A M van der Veldt; Otto S Hoekstra; Maarten Boers; Carla F M Molthoff; Paulus van Diest
Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules.
Clinical endocrinology 2008;68(2):252-7.
2008: Astrid A M van der Veldt; Gert Luurtsema; Mark Lubberink; Adriaan A Lammertsma; N Harry Hendrikse
Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistance.
Current pharmaceutical design 2008;14(28):2914-31.
2008: Helgi H Helgason; Henk A Mallo; Helga Droogendijk; John G Haanen; Astrid A M van der Veldt; Alfons J M van den Eertwegh; Epie Boven
Brain metastases in patients with renal cell cancer receiving new targeted treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):152-4.
2007: Astrid A M van der Veldt; Adriaan A Lammertsma; N Harry Hendrikse
[11C]docetaxel and positron emission tomography for noninvasive measurements of docetaxel kinetics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7522; author reply 7522-3.
2007: Prabath W B Nanayakkara; Astrid A M van der Veldt; Suat Simsek; Yvo M Smulders; Jan A Rauwerda
Verapamil-induced erythermalgia.
The Netherlands journal of medicine 2007;65(9):349-51.
2007: Astrid A M van der Veldt; Alfons J M van den Eertwegh; K Hoekman; F Barkhof; Epie Boven
Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1747-50.
2007: Astrid A M van der Veldt; Sebastiaan A Kleijn; Paula J M Pernet; Roelof-Jan Oostra; Maaike C E Jansweijer
Unilateral partial absence of the fallopian tube in Williams syndrome: a new feature?
Clinical dysmorphology 2007;16(3):195-6.
2007: Astrid A M van der Veldt; Alfons J M van den Eertwegh; E Boven
[Adverse effects of the tyrosine-kinase inhibitor sunitinib, a new drug for the treatment of advanced renal-cell cancer].
Nederlands tijdschrift voor geneeskunde 2007;151(20):1142-7.
2006: Astrid A M van der Veldt; Lotty Hooft; Paulus van Diest; Johannes Berkhof; Marrije R Buist; Emile F I Comans; Otto S Hoekstra; Carla F M Molthoff
Microvessel density and p53 in detecting cervical cancer by FDG PET in cases of suspected recurrence.
European journal of nuclear medicine and molecular imaging 2006;33(12):1408-16.
2006: Astrid A M van der Veldt; Muhammed Hadithi; Marinus A Paul; Fred G van den Berg; Chris J J Mulder; Mikael E Craanen
An unusual cause of hematemesis: Goiter.
World journal of gastroenterology : WJG 2006;12(33):5412-5.
2005: Lotty Hooft; Astrid A M van der Veldt; Paulus van Diest; Otto S Hoekstra; Johannes Berkhof; Gerrit J J Teule; Carla F M Molthoff
[18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor.
The Journal of clinical endocrinology and metabolism 2005;90(1):328-34.